Mark van Duin

A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

Stefan Gröschel, Mathijs A. Sanders, Remco M. Hoogenboezem et al. · Cell · 2014 · 715 citations · Full text

Medicine, Genetics, Molecular Genetics +12

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

Inger S. Nijhof, Tineke Casneuf, Jeroen van Velzen et al. · Blood · 2016 · 380 citations · Full text

Life Sciences, Immunology, Oncology +13

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Annemiek Broyl, Dirk Hose, Henk M. Lokhorst et al. · Blood · 2010 · 338 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

A gene expression signature for high-risk multiple myeloma

Rowan Kuiper, Annemiek Broyl, Yvonne de Knegt et al. · Leukemia · 2012 · 303 citations

Medicine, Molecular Biology, Oncology +14

Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance

Mark van Duin, Peter J.F. Snijders, Henri F.J. Schrijnemakers et al. · International Journal of Cancer · 2002 · 259 citations · Full text

Medicine, Oncology, Pathology +17